Community Service: How Joshua J. Joseph, MD, MPH, Is Leveling the Healthcare Playing Field for All
Investigators Describe Changes to Pancreatic Beta-Cell at Onset of Type 1 Diabetes
New research by investigators at Joslin Diabetes Center sheds new light on the specific changes β-cells go through at the onset of type 1 diabetes. Their findings—published in Nature Cell Biology—offer new avenues for targeted interventions for the chronic autoimmune condition. “In the field of type 1 diabetes, research has largely focused on understanding the immune...
Liraglutide Increases Insulin Sensitivity Independent of Weight Loss, Study Shows
Liraglutide, the glucagon-like peptide-1 receptor (GLP-1R) agonist used to treat type 2 diabetes and obesity, can lead to rapid improvement in insulin sensitivity, according to a study recently published in Diabetes. “We know that GLP-1R agonists promote weight loss, but we were surprised to find that the GLP-1R agonist liraglutide also has rapid effects on...
Endocrine Society Recommends Bipartisan Solutions to Senate HELP Hearing on Diabetes, Obesity
The Endocrine Society commends the Senate Health, Education, Labor, and Pensions (HELP) Committee for calling attention to the issues that are fueling the diabetes epidemic in its December 14’s hearing and urges the Committee to support bipartisan legislation to begin to address the crisis in our country. More than 38 million Americans have diabetes, and...
Fresh from receiving a 2022 Endocrine Society Early Investigator Award, Estelle Everett, MD, MHS, was a member of this year’s Dimensions in Diabetes program that took place in Mumbai, India, in August. She talks to Endocrine News about that program, her own research, and how the award has impacted her career. In August 2023,...
Sage Advice: Reducing the Risk of Hypoglycemia in Older Adults with Diabetes
Pharm Fresh: What Pharmacological Solutions Could Play a Role in Preventing Diabetes?
Software Company Simplifies Glycemic Management for Clinicians and Pharmacists
In August, the insulin management software company Glytec unveiled the latest version of its Glucommander insulin dosing software to make it easier for providers, nurses, and pharmacists to offer optimal, personalized care. More than 300 hospitals in the U.S. use Glytec’s eGlycemic Management System® (eGMS®) for glycemic management for their patients. Glytec chief medical officer...